We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
+14.69%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
10 Year Est. Return
AUM
$4.91B
AUM Growth
+$603M
Cap. Flow
+$14.5M
Cap. Flow %
0.29%
Top 10 Hldgs %
23.21%
Holding
1,377
New
62
Increased
512
Reduced
253
Closed
35

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$12.4M
2
MSFT icon
Microsoft
MSFT
+$9.88M
3
OGE icon
OGE Energy
OGE
+$9.67M
4
VZ icon
Verizon
VZ
+$9.67M
5
ALLY icon
Ally Financial
ALLY
+$8.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.1M
2
CI icon
Cigna
CI
+$18M
3
ALL icon
Allstate
ALL
+$13.6M
4
BA icon
Boeing
BA
+$11.6M
5
IFF icon
International Flavors & Fragrances
IFF
+$11M

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Financials 14.44%
3 Healthcare 13.82%
4 Consumer Discretionary 13.32%
5 Industrials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUT icon
1351
Outfront Media
OUT
$5.29B
-48,950
Closed -$873K
PCG icon
1352
PG&E
PCG
$38.3B
-37,158
Closed -$883K
PR
1353
Permian Resources
PR
$18B
-17,640
Closed -$194K
PTGX icon
1354
Protagonist Therapeutics
PTGX
$9.84B
-286
Closed -$2K
SCCO icon
1355
Southern Copper
SCCO
$165B
-6,917
Closed -$195K
SGMO
1356
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-22,540
Closed -$259K
SLDB icon
1357
Solid Biosciences
SLDB
$971M
-55
Closed -$22K
SRRK icon
1358
Scholar Rock
SRRK
$6.55B
-140
Closed -$3K
TARA icon
1359
Protara Therapeutics
TARA
$219M
-47
Closed -$4K
TPST icon
1360
Tempest Therapeutics
TPST
$19.3M
-2
Closed -$3K
TWI icon
1361
Titan International
TWI
$450M
-3,536
Closed -$16K
VICI icon
1362
VICI Properties
VICI
$28.7B
-144,058
Closed -$2.71M
EIGR
1363
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
-7
Closed -$2K
EXPR
1364
DELISTED
Express, Inc.
EXPR
-939
Closed -$96K
PRTK
1365
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-2,288
Closed -$12K
IMMU
1366
DELISTED
Immunomedics Inc
IMMU
-2,184
Closed -$31K
RST
1367
DELISTED
ROSETTA STONE INC
RST
-9,894
Closed -$162K
AIMT
1368
DELISTED
Aimmune Therapeutics
AIMT
-840
Closed -$20K
SNNA
1369
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
-7,344
Closed -$17K
VSM
1370
DELISTED
Versum Materials, Inc.
VSM
-21,658
Closed -$600K
LABL
1371
DELISTED
Multi-Color Corp
LABL
-3,196
Closed -$112K
ULTI
1372
DELISTED
Ultimate Software Group Inc
ULTI
-4,956
Closed -$1.21M
TFCFA
1373
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-2,380
Closed -$115K
TFCF
1374
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
-1,092
Closed -$52K
SCG
1375
DELISTED
Scana
SCG
-112
Closed -$5K

Similar funds

Meadow Creek Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Meadow Creek Investment Management held 1,377 positions worth $4.91B, up 14% from $4.31B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meadow Creek Investment Management's Q1 2019 filing shows 62 new, 512 increased, 253 reduced and 35 closed positions. Its largest new stake was Celanese: 49,308 shares worth $4.86M. The largest sale was Celgene Corp, an estimated $25.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Meadow Creek Investment Management's largest Q1 2019 buy was Celanese: 49,308 shares worth $4.86M.
  • Meadow Creek Investment Management added most to Eaton in Q1 2019, an estimated $12.4M increase.
  • Meadow Creek Investment Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $25.1M.
  • Meadow Creek Investment Management fully exited VICI Properties in Q1 2019, selling an estimated $2.71M.
  • Meadow Creek Investment Management's ten largest holdings make up 23% of its $4.91B portfolio in Q1 2019.
  • Meadow Creek Investment Management opened 62 new positions and closed 35 in Q1 2019.
  • Meadow Creek Investment Management's portfolio value rose 14% quarter-over-quarter to $4.91B.

Based on Meadow Creek Investment Management's 13F filing for Q1 2019, filed 13 May 2019.